1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Esclerosis Múltiple

Esclerosis Múltiple

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • de la Hera B, Urcelay E, Brassat D, Chan A, Vidal-Jordana A, Salmen A, Villar LM, Alvarez-Cermeño JC, Izquierdo G, Fernández O, Oliver B, Saiz A, Ara JR, Vigo AG, Arroyo R, Meca V, Malhotra S, Fissolo N, Horga A, Montalban X, Comabella M.

    Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 1(4): .

    [doi:10.1212/NXI.0000000000000047]

  • Cantó E, Tintoré M, Villar LM, Borrás E, Alvarez-Cermeño JC, Chiva C, Sabidó E, Rovira A, Montalban X, Comabella M.

    Validation of semaphorin 7A and ala-beta-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis

    JOURNAL OF NEUROINFLAMMATION . 11: 181-181. Nº de citas: 19

    [doi:10.1186/s12974-014-0181-8]

  • Fernández Ó, Álvarez-Cermeño JC, Arnal-García C, Arroyo-González R, Brieva L, Calles-Hernández MC, Casanova-Estruch B, Comabella M, García-Merino JA, Izquierdo G, Meca-Lallana J, Mendibe-Bilbao Mdel M, Muñoz-García D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Prieto J, Ramió-Torrentà L, Romero-Pinel L, Saiz A, Rodríguez-Antigüedad A, Grupo Post-ECTRIMS.

    Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III)

    REVISTA DE NEUROLOGIA . 59(8): 371-379. Nº de citas: 4

    [doi:10.33588/rn.5908.2014335]

  • Fernández Ó, Álvarez-Cermeño JC, Arnal-García C, Arroyo-González R, Brieva L, Calles-Hernández MC, Casanova-Estruch B, Comabella M, García-Merino JA, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao Mdel M, Muñoz-García D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Prieto J, Ramió-Torrentà L, Romero-Pinel L, Saiz A, Rodríguez-Antigüedad A.

    [Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)].

    REVISTA DE NEUROLOGIA . 59(7): 307-316. Nº de citas: 1

    [doi:10.33588/rn.5907.2014334]

  • Beltrán E, Obermeier B, Moser M, Coret F, Simó-Castelló M, Boscá I, Pérez-Miralles F, Villar LM, Senel M, Tumani H, Hohlfeld R, Casanova B, Dornmair K.

    Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation

    Brain . 137(10): 2703-2714. Nº de citas: 50

    [doi:10.1093/brain/awu205]

  • Gnanapavan S, Hegen H, Khalil M, Hemmer B, Franciotta D, Hughes S, Hintzen R, Jeromin A, Havrdova E, Tumani H, Bertolotto A, Comabella M, Frederiksen J, Álvarez-Cermeño JC, Villar L, Galimberti D, Myhr KM, Dujmovic I, Fazekas F, Ionete C, Menge T, Kuhle J, Keir G, Deisenhammer F, Teunissen C, Giovannoni G.

    Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders

    Neurology . 83(13): 1210-1216. Nº de citas: 22

    [doi:10.1212/WNL.0000000000000809]

  • Fernandez O, Alvarez-Cermeno JC, Arnal-Garcia C, Arroyo-Gonzalez R, Brieva L, Calles-Hernandez MC, Casanova-Estruch B, Comabella M, Garcia-Merino JA, Izquierdo G, Meca-Lallana JE, Mendibe-Bilbao MM, Munoz-Garcia D, Olascoaga J, Oliva-Nacarino P, Oreja-Guevara C, Prieto JM, Ramio-Torrenta L, Romero-Pinel L, Saiz A, Rodriguez-Antiguedad A, Grupo Post-Ectrims GP.

    Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)

    REVISTA DE NEUROLOGIA . 59(6): 269-280. Nº de citas: 4

    [doi:10.33588/rn.5906.2014321]

  • de Bock L, Somers K, Fraussen J, Hendriks JJ, van Horssen J, Rouwette M, Hellings N, Villar LM, Alvarez-Cermeño JC, Espiño M, Hupperts R, Jongen P, Damoiseaux J, Verbeek MM, De Deyn PP, D'hooghe M, Van Wijmeersch B, Stinissen P, Somers V.

    Sperm-Associated Antigen 16 Is a Novel Target of the Humoral Autoimmune Response in Multiple Sclerosis

    JOURNAL OF IMMUNOLOGY . 193(5): 2147-2156. Nº de citas: 17

    [doi:10.4049/jimmunol.1401166]

  • Alenda R, Alvarez-Lafuente R, Costa-Frossard L, Arroyo R, Mirete S, Alvarez-Cermeño JC, Villar LM.

    Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis

    EUROPEAN JOURNAL OF NEUROLOGY . 21(8): 1096-1101. Nº de citas: 11

    [doi:10.1111/ene.12435]

  • Villar LM, Casanova B, Ouamara N, Comabella M, Jalili F, Leppert D, de Andrés C, Izquierdo G, Arroyo R, Avsar T, Lapin SV, Johnson T, Montalbán X, Fernández O, Álvarez-Lafuente R, Masterman D, García-Sánchez MI, Coret F, Siva A, Evdoshenko E, Álvarez-Cermeño JC, Bar-Or A.

    Immunoglobulin M Oligoclonal Bands: Biomarker of Targetable Inflammation in Primary Progressive Multiple Sclerosis

    ANNALS OF NEUROLOGY . 76(2): 231-240. Nº de citas: 42

    [doi:10.1002/ana.24190]

  • DeFelipe-Mimbrera A, Masjuan J, Corral Í, Villar LM, Graus F, García-Barragán N.

    Opsoclonus-myoclonus syndrome and limbic encephalitis associated with GABA(B) receptor antibodies in CSF

    JOURNAL OF NEUROIMMUNOLOGY . 272(1-2): 91-93. Nº de citas: 18

    [doi:10.1016/j.jneuroim.2014.04.009]

  • Fernandez O, Martin R, Rovira A, Llufriu S, Vidal-Jordana A, Fernandez-Sanchez VE, Alvarez-Cermeno JC, Izquierdo G, Arroyo-Gonzalez R, Rodriguez-Antiguedad A, Casanova-Estruch B, Montalban X.

    Biomarkers in multiple sclerosis: an update for 2014

    REVISTA DE NEUROLOGIA . 58(12): 553-570. Nº de citas: 8

    [doi:10.33588/rn.5812.2014247]

  • Sáenz-Cuesta M, Irizar H, Castillo-Triviño T, Muñoz-Culla M, Osorio-Querejeta I, Prada A, Sepúlveda L, López-Mato MP, López de Munain A, Comabella M, Villar LM, Olascoaga J, Otaegui D.

    Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis

    BIOMARKERS IN MEDICINE . 8(5): 653-661. Nº de citas: 58

    [doi:10.2217/BMM.14.9]

  • Marín N, Eixarch H, Mansilla MJ, Rodríguez-Martín E, Mecha M, Guaza C, Álvarez-Cermeño JC, Montalban X, Villar LM, Espejo C.

    Anti-myelin antibodies play an important role in the susceptibility to develop proteolipid protein-induced experimental autoimmune encephalomyelitis

    CLINICAL AND EXPERIMENTAL IMMUNOLOGY . 175(2): 202-207. Nº de citas: 4

    [doi:10.1111/cei.12233]

  • González-López JJ, Rebolleda G, Leal M, Oblanca N, Muñoz-Negrete FJ, Costa-Frossard L, Alvarez-Cermeño JC.

    Comparative Diagnostic Accuracy of Ganglion Cell-Inner Plexiform and Retinal Nerve Fiber Layer Thickness Measures by Cirrus and Spectralis Optical Coherence Tomography in Relapsing-Remitting Multiple Sclerosis

    BIOMED RESEARCH INTERNATIONAL . 2014: 128517-128517. Nº de citas: 51

    [doi:10.1155/2014/128517]

  • Marín N, Mecha M, Espejo C, Mestre L, Eixarch H, Montalban X, Álvarez-Cermeño JC, Guaza C, Villar LM.

    Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE

    JOURNAL OF IMMUNOLOGY RESEARCH . 2014: 156380-156380. Nº de citas: 3

    [doi:10.1155/2014/156380]

  • Teunissen C, Menge T, Altintas A, Álvarez-Cermeño JC, Bertolotto A, Berven FS, Brundin L, Comabella M, Degn M, Deisenhammer F, Fazekas F, Franciotta D, Frederiksen JL, Galimberti D, Gnanapavan S, Hegen H, Hemmer B, Hintzen R, Hughes S, Iacobaeus E, Kroksveen AC, Kuhle J, Richert J, Tumani H, Villar LM, Drulovic J, Dujmovic I, Khalil M, Bartos A.

    Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

    MULTIPLE SCLEROSIS JOURNAL . 19(13): 1802-1809. Nº de citas: 94

    [doi:10.1177/1352458513488232]

  • Fernández Ó, Arnal-García C, Arroyo-González R, Brieva L, Calles-Hernández MC, Casanova-Estruch B, Comabella M, de las Heras V, García-Merino JA, Hernández-Pérez MA, Izquierdo G, Matas E, Meca-Lallana JE, Mendibe-Bilbao Mdel M, Muñoz-García D, Olascoaga J, Oreja-Guevara C, Prieto JM, Ramió-Torrentà L, Rodríguez-Antigüedad A, Saiz A, Téllez N, Villar LM, Tintoré M.

    Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III)

    REVISTA DE NEUROLOGIA . 57(7): 317-329. Nº de citas: 11

    [doi:10.33588/rn.5707.2013277]